Hostname: page-component-7479d7b7d-q6k6v Total loading time: 0 Render date: 2024-07-12T20:52:02.910Z Has data issue: false hasContentIssue false
  • English
  • Français

Neuropeptides in Eating Disorders

Published online by Cambridge University Press:  07 November 2014

David C. Jimerson  and
Barbara E. Wolfe
Get access Rights & Permissions [Opens in a new window]

Abstract

The past decade has witnessed a dramatic acceleration in research on the role of the neuropeptides in the regulation of eating behavior and body weight homeostasis. This expanding research focus has been driven in part by increasing public health concerns related to obesity and the eating disorders anorexia nervosa (AN) and bulimia nervosa (BN). Preclinical advances have been facilitated by the development of new molecular and behavioral research methodologies. With a focus on clinical investigations in AN and BN, this article reviews research on selected hypothalamic and gut-related peptide systems with prominent effects on eating behavior. Studies of the orexigenic peptides neuropeptide Y and the opioid peptides have shown state-related abnormalities in patients with eating disorders. With respect to gut-related peptides, there appears to be substantial evidence for blunting in the meal-related release of the satiety promoting peptide cholecystokinin in BN. Fasting plasma levels of the orexigenic peptide ghrelin have been found to be elevated in patients with AN. As discussed in this review, additional studies will be needed to assess the role of nutritional and body weight changes in neuropeptide alterations observed in symptomatic eating disorder patients, and to identify stable trait-related abnormalities in neuropeptide regulation that persist in individuals who have recovered from an eating disorder.

Type
Review Articles
Information
CNS Spectrums , Volume 9 , Issue 7 , July 2004 , pp. 516 - 522
Copyright
Copyright © Cambridge University Press 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1.Yanovski, SZ, Yanovski, JA. Obesity. N Engl J Med. 2002;346:591–602.CrossRefGoogle ScholarPubMed
2.American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed-text rev. Washington, DC: American Psychiatric Association; 2000.Google Scholar
3.Friedman, JM, Halaas, JL. Leptin and the regulation of body weight in mammals. Nature. 1998;395:763–770.CrossRefGoogle ScholarPubMed
4.Tecott, LH, Nestler, EJ. Neurobehavioral assessment in the information age. Nat Neurosci. 2004;7:462–466.CrossRefGoogle ScholarPubMed
5.Heinrichs, SC, Richard, D. The role of corticotropin-releasing factor and urocortin in the modulation of ingestive behavior. Neuropeptides. 1999;33:350–359.CrossRefGoogle ScholarPubMed
6.Kaye, WH, Gwirtsman, HE, George, DT, et al. Elevated cerebrospinal fluid levels of immunoreactive corticotropin-releasing hormone in anorexia nervosa: relation to state of nutrition, adrenal function, and intensity of depression. J Clin Endocnnol Metab. 1987;64:203–208.CrossRefGoogle ScholarPubMed
7.Kaye, WH. Neuropeptide abnormalities in anorexia nervosa. Psychiatry Res. 1996;62:65–74.CrossRefGoogle ScholarPubMed
8.Stoving, RK, Hangaard, J, Hansen-Nord, M, Hagen, C. A review of endocrine changes in anorexia nervosa. J Psychiatr Res. 1999;33:139–152.CrossRefGoogle ScholarPubMed
9.Kissileff, HR, Wentzlaff, TH, Guss, JL, Walsh, BT, Devlin, MJ, Thornton, JC. A direct measure of satiety disturbance in patients with bulimia nervosa. Physiol Behav. 1996;60:1077–1085.CrossRefGoogle ScholarPubMed
10.Jimerson, DC, Wolfe, BE. Eating disorders: neurobiology and symptomatology. In: Asbury, AK, McKhann, GM, McDonald, WI, Goadsby, PJ, McArthur, JC, eds. Diseases of the Nervous System: Clinical Neuroscience and Therapeutic Principles. 3rd ed. Cambridge, UK: Cambridge University Press; 2002;808–815.CrossRefGoogle Scholar
11.Sunday, SR, Halmi, KA. Micro- and macroanalyses of patterns within a meal in anorexia and bulimia nervosa. Appetite. 1996;26:21–36.CrossRefGoogle ScholarPubMed
12.Woods, SC, Schwartz, MW, Baskin, DG, Seeley, RJ. Food intake and the regulation of body weight. Annu Rev Psychol. 2000;51:255–277.CrossRefGoogle ScholarPubMed
13.Zigman, JM, Elmquist, JK. Minireview: From anorexia to obesity—the yin and yang of body weight control. Endocrinology. 2003;144:3749–3756.CrossRefGoogle ScholarPubMed
14.Schwartz, MW, Baskin, DG, Kaiyala, KJ, Woods, SC. Model for the regulation of energy balance and adiposity by the central nervous system. Am J Clin Nutr. 1999;69:584–596.CrossRefGoogle ScholarPubMed
15.American Psychiatric Association Workgroup on Eating Disorders. Practice guideline for the treatment of patients with eating disorders [revision]. Am J Psychiatry. 2000;157:1–39.Google Scholar
16.Kaye, WH, Strober, M, Jimerson, DC. The neurobiology of eating disorders. In: Chamey, DS, Nestler, EJ, eds. The Neurobiology of Mental Illness. Oxford: Oxford University Press; 2004;1112–1128.Google Scholar
17.Mantzoros, C, Flier, JS, Lesem, MD, Brewerton, TD, Jimerson, DC. Cerebrospinal fluid leptin in anorexia nervosa: correlation with nutritional status and potential role in resistance to weight gain. J Clin Endocrinol Metab. 1997;82:1845–1851.Google ScholarPubMed
18.Neary, NM, Small, CJ, Bloom, SR. Gut and mind. Gut. 2003;52:918–921.CrossRefGoogle ScholarPubMed
19.Tatemoto, K, Carlquist, M, Mutt, V. Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 1982;296:659–660.CrossRefGoogle ScholarPubMed
20.Gehlert, DR. Role of hypothalamic neuropeptide Y in feeding and obesity. Neumpeptides. 1999;33:329–338.CrossRefGoogle ScholarPubMed
21.Leibowitz, SF, Alexander, JT. Analysis of neuropeptide Y-induced feeding: dissociation of Y1 and Y2 receptor effects on natural meal patterns. Peptides. 1991;12:1251–1260.CrossRefGoogle ScholarPubMed
22.Erickson, JC, Hollopeter, G, Palmiter, RD. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y. Science. 1996;274:1704–1707.CrossRefGoogle Scholar
23.Kalra, SP, Dube, MG, Sahu, A, Phelps, CP, Kalra, PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA. 1991;88:10931–10935.CrossRefGoogle ScholarPubMed
24.Zarjevski, N, Cusin, I, Vettor, R, Rohner-Jeanrenaud, F, Jeanrenaud, B. Chronic intracerebroventricular neuropeptide-Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology. 1993;133:1753–1758.CrossRefGoogle ScholarPubMed
25.Kaye, WH, Berrettini, W, Gwirtsman, H, George, DT. Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa. Arch Gen Psychiatry. 1990;47:548–556.CrossRefGoogle ScholarPubMed
26.Gendall, KA, Kaye, WH, Altemus, M, McConaha, CW, La Via, MC. Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients. Biol Psychiatry. 1999;46:292–299.CrossRefGoogle ScholarPubMed
27.Nedvidkova, J, Papezova, H, Haluzik, M, Schreiber, V. Interaction between serum leptin levels and hypothalamo-hypophyseal-thyroid axis in patients with anorexia nervosa. Endocr Res. 2000;26:219–230.CrossRefGoogle ScholarPubMed
28.Baranowska, B, Wolinska-Witort, E, Wasilewska-Dziubinska, E, Roguski, K, Chmielowska, M. Plasma leptin, neuropeptide Y (NPY) and galanin concentrations in bulimia nervosa and in anorexia nervosa. Neuroendocrinol Lett. 2001;22:356–358.Google ScholarPubMed
29.Levine, AS, Morley, JE, Gosnell, BA, Billington, CJ, Bartness, TJ. Opioids and consummatory behavior. Brain Res Bull. 1985;14:663–672.CrossRefGoogle ScholarPubMed
30.Glass, MJ, Billington, CJ, Levine, AS. Opioids and food intake: distributed functional neural pathways? Neuropeptides. 1999;33:360–368.CrossRefGoogle ScholarPubMed
31.Zhang, M, Gosnell, BA, Kelley, AE. Intake of high-fat food is selectively enhanced by mu opioid receptor stimulation within the nucleus accumbens. J Pharmacol Exp Ther. 1998;285:908–914.Google ScholarPubMed
32.de Zwaan, M, Mitchell, JE. Opiate antagonists and eating behavior in humans: a review. J Clin Pharmacol. 1992;32:1060–1072.CrossRefGoogle ScholarPubMed
33.Gerner, RH, Sharp, B. CSF beta-endorphin-immunoreactivity in normal, schizophrenic, depressed, manic and anorexic subjects. Brain Res. 1982;237:244–247.CrossRefGoogle ScholarPubMed
34.Lesem, MD, Berrettini, WH, Kaye, WH, Jimerson, DC. Measurement of CSF dynorphin A 1-8 immunoreactivity in anorexia nervosa and normal-weight bulimia. Biol Psychiatry. 1991;29:244–252.CrossRefGoogle ScholarPubMed
35.Baranowska, B. Are disturbances in opioid and adrenergic systems involved in the hormonal dysfunction of anorexia nervosa? Psychoneuroeniocrinology. 1990;15:371–379.CrossRefGoogle ScholarPubMed
36.Brambilla, F, Ferrari, E, Petraglia, F, Facchinetti, F, Catalano, M, Genazzani, AR. Peripheral opioid secretory pattern in anorexia nervosa. Psychiatry Res. 1991;39:115–127.CrossRefGoogle ScholarPubMed
37.Brambilla, F, Brunetta, M, Peirone, A, Perna, G, Sacerdote, P, Manfredi, B, Panerai, AE. T-lymphocyte cholecystokinin-8 and beta-endorphin concentrations in eating disorders: I. Anorexia nervosa. Psychiatry Res. 1995;59:43–50.CrossRefGoogle ScholarPubMed
38.Brewerton, TD, Lydiard, RB, Laraia, MT, Shook, JE, Ballenger, JC. CSF beta-endorphin and dynorphin in bulimia nervosa. Am J Psychiatry. 1992;149:1086–1090.Google ScholarPubMed
39.Waller, DA, Kiser, RS, Hardy, BW, Fuchs, I, Feigenbaum, LP, Uauy, R. Eating behavior and plasma beta-endorphin in bulimia. Am J Clin Nutr. 1986;44:20–23.CrossRefGoogle ScholarPubMed
40.Brambilla, F, Brunetta, M, Dtaisci, A, et al. T-lymphocyte concentrations of cholecystokinin-8 and beta-endorphin in eating disorders: II. Bulimia nervosa. Psychiatry Res. 1995;59:51–56.CrossRefGoogle ScholarPubMed
41.Mitchell, JE, Laine, DE, Morley, JE, Levine, AS. Naloxone but not CCK-8 may attenuate binge-eating behavior in patients with the bulimia syndrome. Biol Psychiatry. 1986;21:1399–1406.CrossRefGoogle Scholar
42.Vergoni, AV, Bertolini, A. Role of melanocortins in the central control of feeding. Eur J Pharmacol. 2000;405:25–32.CrossRefGoogle ScholarPubMed
43.Koegler, FH, Grove, KL, Schiffmacher, A, Smith, MS, Cameron, JL. Central melanocortin receptors mediate changes in food intake in the rhesus macaque. Endocrinology. 2001;142:2586–2592.CrossRefGoogle ScholarPubMed
44.Heisler, LK, Cowley, MA, Tecott, LH, et al. Activation of central melanocortin pathways by fenfluramine. Science. 2002;297:609–611.CrossRefGoogle ScholarPubMed
45.Farooqi, IS, Yeo, GS, O'Rahilly, S. Binge eating as a phenotype of melanocortin 4 receptor gene mutations. N Engl J Med. 2003;349:606–609.Google ScholarPubMed
46.Branson, R, Potoczna, N, Krai, JG, Lentes, KU, Hoehe, MR, Horber, FF. Binge eating as a major phenotype of melanocortin 4 teceptor gene mutations. N Engl J Med. 2003;348:1096–1103.CrossRefGoogle Scholar
47.Fetissov, SO, Hallman, J, Oreland, L, et al. Autoantibodies against alpha -MSH, ACTH, and LHRH in anorexia and bulimia nervosa patients. Proc Natl Acad Sci USA. 2002;99:17155–17160.CrossRefGoogle ScholarPubMed
48.Lu, D, Willard, D, Patel, IR, et al. Agouti protein is an antagonist of the melanocyte-stimulatlng-hormone receptor. Nature. 1994;371:799–802.CrossRefGoogle ScholarPubMed
49.Kas, MJ, van Dijk, G, Scheurink, AJ, Adan, RA. Agouti-related protein prevents self-starvation. Mol Psychiatry. 2003;8:235–240.CrossRefGoogle ScholarPubMed
50.Vink, T, Hinney, A, van Elburg, AA, et al. Association between an agoutitelated protein gene polymorphism and anorexia nervosa. Mol Psychiatry. 2001;6:325–328.CrossRefGoogle ScholarPubMed
51.Jimerson, DC, Mantzoros, C, Wolfe, BE, Metzger, ED. Decreased serum leptin in bulimia nervosa. J Clin Endocrinol Metab. 2000;85:4511–4514.Google ScholarPubMed
52.Jimerson, DC. Leptin and the neurobiology of eating disorders. J Lab Clin Med. 2002;139:70–71.CrossRefGoogle ScholarPubMed
53.Pannacciulli, N, Vettor, R, Milan, G, et al. Anorexia nervosa is characterized by increased adiponectin plasma levels and reduced nonoxidative glucose metabolism. J Clin Endocrinol Metab. 2003;88:1748–1752.CrossRefGoogle ScholarPubMed
54.Delporte, ML, Btichatd, SM, Hermans, MP, Beguin, C, Lambert, M. Hyperadiponectinaemia in anorexia nervosa. Clin Endocrinol (Oxf). 2003;58:22–29.CrossRefGoogle ScholarPubMed
55.Iwahashi, H, Funahashi, T, Kurokawa, N, et al. Plasma adiponectin levels in women with anorexia nervosa. Horm Metab Res. 2003;35:537–540.Google ScholarPubMed
56.Wolfe, BE, Jimerson, DC, Orlova, C, Mantzoros, CS. Effect of dieting on plasma leptin, soluble leptin receptor, adiponectin and resistin levels in healthy volunteets. Clin Endocrinol. In press.Google Scholar
57.Gibbs, J, Young, RC, Smith, GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol. 1973;84:488–495.CrossRefGoogle ScholarPubMed
58.Kissileff, HR, Pi-Sunyer, FX, Thornton, J, Smith, GP. C-terminal octapeptide of cholecystokinin decreases food intake in man. Am J Clin Nutr. 1981;34:154–160.CrossRefGoogle ScholarPubMed
59.Moran, TH, Kinzig, KP. Gastrointestinal satiety signals II. Cholecystokinin. Am J Physiol Gastrointest Liver Physiol. 2004;286:G183–G188.CrossRefGoogle ScholarPubMed
60.Blevins, JE, Stanley, BG, Reidelberger, RD. Brain regions where cholecystokinin suppresses feeding in rats. Brain Res. 2000;860:1–10.CrossRefGoogle ScholarPubMed
61.Gerner, RH, Yamada, T. Altered neuropeptide concentrations in cerebrospinal fluid of psychiatric patients. Brain Res. 1982;238:298–302.CrossRefGoogle ScholarPubMed
62.Geracioti, TD Jr, Liddle, RA, Altemus, M, Demitrack, MA, Gold, PW. Regulation of appetite and cholecystokinin secretion in anorexia nervosa. Am J Psychiatry. 1992;149:958–961.Google ScholarPubMed
63.Pirke, KM, Kellner, MB, Friess, E, Krieg, JC, Renter, MM. Satiety and cholecystokinin. Int J Eat Disord. 1994;15:63–69.3.0.CO;2-V>CrossRefGoogle ScholarPubMed
64.Lydiard, RB, Brewerton, TD, Fossey, MD, et al. CSF cholecystokinin octapeptide in patients with bulimia nervosa and in normal comparison subjects. Am J Psychiatry. 1993;150:1099–1101.Google ScholarPubMed
65.Geracioti, TD Jr, Liddle, RA. Impaired cholecystokinin secretion in bulimia nervosa. N Engl J Med. 1988;319:683–688.CrossRefGoogle ScholarPubMed
66.Devlin, MJ, Walsh, BT, Guss, JL, Kissileff, HR, Liddle, RA, Petkova, E. Postprandial cholecystokinin release and gastric emptying in patients with bulimia nervosa. Am J Clin Nutr. 1997;65:114–120.CrossRefGoogle ScholarPubMed
67.Geliebter, A, Melton, PM, McCray, RS, Gallagher, DR, Gage, D, Hashim, SA. Gastric capacity, gastric emptying, and test-meal intake in normal and bulimic women. Am J Clin Nutr. 1992;56:656–661.CrossRefGoogle ScholarPubMed
68.Walsh, BT, Zimmerli, E, Devlin, MJ, Guss, J, Kissileff, HR. A disturbance of gastric function in bulimia nervosa. Biol Psychiatry. 2003;54:929–933.CrossRefGoogle ScholarPubMed
69.Ariyasu, H, Takaya, K, Tagami, T, et al. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans. J Clin Endocrinol Metab. 2001;86:4753–4758.CrossRefGoogle Scholar
70.Chen, HY, Trumbauer, ME, Chen, AS, et al. Orexigenic action of peripheral ghrelin is mediated by neuropeptide Y (NPY) and agouti-related protein (AgRP). Endocrinology. 2004;145:2607–2612.CrossRefGoogle ScholarPubMed
71.Wren, AM, Seal, LJ, Cohen, MA, et al. Ghrelin enhances appetite and increases food intake in humans. J Clin Endocrinol Metab. 2001;86:5992–5995.CrossRefGoogle ScholarPubMed
72.Cummings, DE, Weigle, DS, Frayo, RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–1630.CrossRefGoogle ScholarPubMed
73.Otto, B, Cuntz, U, Fruehauf, E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrimol. 2001;145:669–673.CrossRefGoogle ScholarPubMed
74.Shiiya, T, Nakazato, M, Mizuta, M, et al. Plasma ghrelin levels in lean and obese humans and the effect of glucose on ghrelin secretion. J Clin Endocrinol Metab. 2002;87:240–244.CrossRefGoogle ScholarPubMed
75.Tanaka, M, Naruo, T, Nagai, N, et al. Habitual binge/purge behavior influences circulating ghrelin levels in eating disorders. J Psychiatr Res. 2003;37:17–22.CrossRefGoogle ScholarPubMed
76.Soriano-Guillén, L, Barrios, V, Campos-Barros, Á, Argente, J. Ghrelin levels in obesity and anorexia nervosa: effect of weight reduction or recuperation. J Pediatr. 2004;144:36–42.CrossRefGoogle ScholarPubMed
77.Tolle, V, Kadem, M, Bluet-Pajot, MT, et al. Balance in ghrelin and leptin plasma levels in anorexia nervosa patients and constitutionally thin women. J Clin Endocrinol Metab. 2003;88:109–116.CrossRefGoogle ScholarPubMed
78.Tanaka, M, Naruo, T, Yasuhara, D, et al. Fasting plasma ghrelin levels in subtypes of anorexia nervosa. Psychoneuroendocrinology. 2003;28:829–835.CrossRefGoogle ScholarPubMed
79.Nedvídková, J, Krykorková, I, Barták, V, et al. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab. 2003;88:1678–1682.CrossRefGoogle ScholarPubMed
80.Nakai, Y, Hosoda, H, Nin, K, et al. Plasma levels of active form of ghrelin during oral glucose tolerance test in patients with anorexia nervosa. Eur J Endocrinol. 2003;149:R1–R3.CrossRefGoogle ScholarPubMed
81.Tanaka, M, Tatebe, Y, Nakahara, T, et al. Eating pattern and the effect of oral glucose on ghrelin and insulin secretion in patients with anorexia nervosa. Clin Endocrinol (Oxf). 2003;59:574–579.CrossRefGoogle ScholarPubMed
82.Tanaka, M, Naruo, T, Muranaga, T, et al. Increased fasting plasma ghrelin levels in patients with bulimia nervosa. Eur J Endocrinol. 2002;146:R1–R3.CrossRefGoogle ScholarPubMed
83.Monteleone, P, Martiadis, V, Fabrazzo, M, Serritella, C, Maj, M. Ghrelin and leptin responses to food ingestion in bulimia nervosa: implications for bingeeating and compensatory behaviors. Psychol Med. 2003;33:1387–1394.CrossRefGoogle Scholar
84.Batterham, RL, Cowley, MA, Small, CJ, et al. Gut hormone PYY(3-36). physiologically inhibits food intake. Nature. 2002;418:650–654.CrossRefGoogle ScholarPubMed
85.Batterham, RL, Cohen, MA, Ellis, SM, et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med. 2003;349:941–948.CrossRefGoogle ScholarPubMed